What is United Therapeutics's gross profit?

United Therapeutics (UTHR) reported gross profit of $648.1M in Q1 2026.

How has United Therapeutics's gross profit changed year-over-year?

United Therapeutics's gross profit decreased by 7.7% year-over-year, from $701.9M to $648.1M.

What is the long-term trend for United Therapeutics's gross profit?

Over 4 years (2021 to 2025), United Therapeutics's gross profit has grown at a 15.7% compound annual growth rate (CAGR), from $1.56B to $2.8B.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

United Therapeutics UTHR Gross Profit

Gross Profit at other companies

Johnson & JohnsonJNJ

$15.96B+9.8%

Merck & Co.MRK

$12.09B-0.2%

LQD

Liquidia CorporationLQDA

$1.6M+6.5%

AmgenAMGN

$5.87B+13.4%

ANI PharmaceuticalsANIP

$143.88M+16.0%

Zevra Therapeutics, Inc.ZVRA

$34.32M+80.1%

Segments

By product

See full

Tyvaso DPI$247.1M-2.9%

Orenitram$128.2M+14.1%

Nebulized Tyvaso$118.6M-23.6%

Remodulin$110.5M-11.2%

Unituxin$48.6M-8.3%

Adcirca$1.9M-44.1%

Other financials

Income statement

See full

Revenue$781.5M-1.6%

Operating income$325.8M-14.9%

Net income$274.9M-14.7%

EPS (diluted)$5.82-12.2%

Balance sheet

See full

Cash & equivalents$1.3B-32.6%

Total debt$12.2M—

Total equity$5.9B-13.3%

Total assets$6.7B-13.3%

Cash flow

See full

Operating cash flow$463.3M+0.5%

CapEx$100.8M+34.6%

Free cash flow$362.5M-6.2%

Valuation

See full

Market cap$23B+84.1%

P/E17.9×+7.8×

P/S7.3×+3.2×

Profitability

See full

Gross margin86.6%-2.4pp

Operating margin45.3%-1.6pp

Net margin40.6%+0.2pp

FCF margin32.1%-5.6pp

Returns & leverage

See full

Return on equity20.3%+0.3pp

Debt / equity0×—

Current ratio4.8×-0.7×

Where this comes from

Calculated from United Therapeutics’s reported figures.

$781.5Mtotal revenue−$133.4Mtotal cost of revenue=$648.1M

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is United Therapeutics's gross profit?: United Therapeutics (UTHR) reported gross profit of $648.1M in Q1 2026.
How has United Therapeutics's gross profit changed year-over-year?: United Therapeutics's gross profit decreased by 7.7% year-over-year, from $701.9M to $648.1M.
What is the long-term trend for United Therapeutics's gross profit?: Over 4 years (2021 to 2025), United Therapeutics's gross profit has grown at a 15.7% compound annual growth rate (CAGR), from $1.56B to $2.8B.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.